JP2009131831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009131831A5 JP2009131831A5 JP2008232913A JP2008232913A JP2009131831A5 JP 2009131831 A5 JP2009131831 A5 JP 2009131831A5 JP 2008232913 A JP2008232913 A JP 2008232913A JP 2008232913 A JP2008232913 A JP 2008232913A JP 2009131831 A5 JP2009131831 A5 JP 2009131831A5
- Authority
- JP
- Japan
- Prior art keywords
- processing
- fluid
- pressure
- ring
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012530 fluid Substances 0.000 claims description 502
- 238000006243 chemical reaction Methods 0.000 claims description 95
- 239000010419 fine particle Substances 0.000 claims description 95
- 239000010409 thin film Substances 0.000 claims description 53
- 238000002156 mixing Methods 0.000 claims description 40
- 238000004519 manufacturing process Methods 0.000 claims description 35
- 239000002245 particle Substances 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 20
- 238000001556 precipitation Methods 0.000 claims description 15
- 230000001376 precipitating Effects 0.000 claims description 13
- 238000003825 pressing Methods 0.000 claims description 13
- 230000002829 reduced Effects 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 238000007872 degassing Methods 0.000 claims description 4
- 238000004807 desolvation Methods 0.000 claims description 3
- 239000011859 microparticle Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 description 47
- 239000000047 product Substances 0.000 description 33
- MKUXAQIIEYXACX-UHFFFAOYSA-N acyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 28
- 229940023040 Acyclovir Drugs 0.000 description 27
- 229960004150 aciclovir Drugs 0.000 description 27
- 238000000034 method Methods 0.000 description 27
- 238000010438 heat treatment Methods 0.000 description 25
- 230000002093 peripheral Effects 0.000 description 24
- 238000001816 cooling Methods 0.000 description 21
- 230000037250 Clearance Effects 0.000 description 17
- 230000035512 clearance Effects 0.000 description 17
- 239000007788 liquid Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000011144 upstream manufacturing Methods 0.000 description 10
- 230000000875 corresponding Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000007667 floating Methods 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000006073 displacement reaction Methods 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000003247 decreasing Effects 0.000 description 6
- 239000002105 nanoparticle Substances 0.000 description 5
- FLJPGEWQYJVDPF-UHFFFAOYSA-L Caesium sulfate Chemical compound [Cs+].[Cs+].[O-]S([O-])(=O)=O FLJPGEWQYJVDPF-UHFFFAOYSA-L 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000005712 crystallization Effects 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 230000003746 surface roughness Effects 0.000 description 4
- 230000002463 transducing Effects 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- -1 sucrose fatty acid ester Chemical class 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L Calcium hydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000002706 hydrostatic Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000001678 irradiating Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 206010003816 Autoimmune disease Diseases 0.000 description 1
- YCSMVPSDJIOXGN-UHFFFAOYSA-N CCCCCCCCCCCC[Na] Chemical compound CCCCCCCCCCCC[Na] YCSMVPSDJIOXGN-UHFFFAOYSA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M Dioctyl sodium sulfosuccinate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- 206010014599 Encephalitis Diseases 0.000 description 1
- 208000007514 Herpes Zoster Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 229940067606 Lecithin Drugs 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N Silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 229940083575 Sodium Dodecyl Sulfate Drugs 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- FPKOPBFLPLFWAD-UHFFFAOYSA-N Trinitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1[N+]([O-])=O FPKOPBFLPLFWAD-UHFFFAOYSA-N 0.000 description 1
- UONOETXJSWQNOL-UHFFFAOYSA-N Tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 1
- MDYZKJNTKZIUSK-UHFFFAOYSA-N Tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 229910007946 ZrB Inorganic materials 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N carbodiimide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 201000006082 chickenpox Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229950008597 drug INN Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 239000011346 highly viscous material Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 239000010722 industrial gear oil Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 201000009906 meningitis Diseases 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 201000002674 obstructive nephropathy Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000452 restraining Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940067741 sodium octyl sulfate Drugs 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical compound [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 description 1
- SMECTXYFLVLAJE-UHFFFAOYSA-M sodium;pentadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCOS([O-])(=O)=O SMECTXYFLVLAJE-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 229960004224 tyloxapol Drugs 0.000 description 1
- 229920001664 tyloxapol Polymers 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008232913A JP4986300B2 (ja) | 2007-11-09 | 2008-09-11 | 微粒子の製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007291820 | 2007-11-09 | ||
| JP2007291820 | 2007-11-09 | ||
| JP2008232913A JP4986300B2 (ja) | 2007-11-09 | 2008-09-11 | 微粒子の製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054063A Division JP5376476B2 (ja) | 2007-11-09 | 2012-03-12 | 微粒子の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009131831A JP2009131831A (ja) | 2009-06-18 |
| JP2009131831A5 true JP2009131831A5 (fr) | 2011-09-29 |
| JP4986300B2 JP4986300B2 (ja) | 2012-07-25 |
Family
ID=40864291
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008232913A Active JP4986300B2 (ja) | 2007-11-09 | 2008-09-11 | 微粒子の製造方法 |
| JP2012054063A Active JP5376476B2 (ja) | 2007-11-09 | 2012-03-12 | 微粒子の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054063A Active JP5376476B2 (ja) | 2007-11-09 | 2012-03-12 | 微粒子の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP4986300B2 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010061430A1 (fr) | 2008-11-25 | 2010-06-03 | エム・テクニック株式会社 | Matériel de traitement de fluide et procédé de traitement |
| EP2578311B1 (fr) * | 2010-05-25 | 2018-03-28 | M Technique Co., Ltd. | Procédé de production de substances précipitées contenant des quantités contrôlées d'élément dopant |
| US10350556B2 (en) | 2011-01-07 | 2019-07-16 | Microfluidics International Corporation | Low holdup volume mixing chamber |
| JP5979645B2 (ja) * | 2011-04-01 | 2016-08-24 | エム・テクニック株式会社 | バリウムチタニル塩及びチタン酸バリウムの製造方法 |
| US20150005429A1 (en) | 2012-02-13 | 2015-01-01 | Kyowa Chemical Industry Co., Ltd. | Magnesium hydroxide fine particles |
| WO2013125552A1 (fr) * | 2012-02-21 | 2013-08-29 | エム・テクニック株式会社 | Procédé de fabrication de microparticules |
| JP5895046B2 (ja) * | 2012-03-26 | 2016-03-30 | 協和化学工業株式会社 | ハイドロタルサイト粒子の製造方法 |
| US10166605B2 (en) | 2012-05-01 | 2019-01-01 | M. Technique Co., Ltd. | Method for producing microparticles |
| JPWO2015125819A1 (ja) * | 2014-02-18 | 2017-03-30 | エム・テクニック株式会社 | 微粒子の製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2377661B (en) * | 2001-07-20 | 2005-04-20 | Univ Newcastle | Methods of manufacturing particles |
| JP3955254B2 (ja) * | 2002-11-25 | 2007-08-08 | エム・テクニック株式会社 | 微細化装置付脱気機及び微細化による脱気方法 |
| JP4038083B2 (ja) * | 2002-07-16 | 2008-01-23 | エム・テクニック株式会社 | 分散乳化装置及び分散乳化方法 |
| JP2006341232A (ja) * | 2005-06-10 | 2006-12-21 | Canon Inc | 流体処理装置および流体処理方法 |
| EP2184110B1 (fr) * | 2007-07-06 | 2016-03-23 | M Technique Co., Ltd. | Appareil de traitement de liquide et procédé de traitement |
-
2008
- 2008-09-11 JP JP2008232913A patent/JP4986300B2/ja active Active
-
2012
- 2012-03-12 JP JP2012054063A patent/JP5376476B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5376476B2 (ja) | 微粒子の製造方法 | |
| JPWO2009038008A1 (ja) | 微粒子の製造方法及びその微粒子 | |
| JP4335968B2 (ja) | 金属微粒子の製造方法及びその金属微粒子を含む金属コロイド溶液 | |
| JP2009131831A5 (fr) | ||
| JP4363499B2 (ja) | セラミックスナノ粒子の製造方法 | |
| JP4363498B2 (ja) | 金属担持カーボンの製造方法 | |
| JP4849648B2 (ja) | エマルションの製造方法 | |
| JP2009144250A5 (fr) | ||
| JP5131935B2 (ja) | 流体処理装置及び処理方法 | |
| JPWO2009041274A1 (ja) | 磁性体微粒子の製造方法、これにより得られた磁性体微粒子及び磁性流体、磁性体製品の製造方法 | |
| JP4359858B2 (ja) | 二酸化チタン超微粒子の製造方法 | |
| JP5821072B2 (ja) | 流体処理装置及び処理方法 | |
| JP5382738B2 (ja) | 流体処理装置及び処理方法 | |
| JP4446129B1 (ja) | 微粒子の製造方法 | |
| JP4446128B1 (ja) | 微粒子の製造方法 | |
| JP2009132994A (ja) | 磁性体微粒子の製造方法、これにより得られた磁性体微粒子及び磁性流体、磁性体製品の製造方法 | |
| JP2009242785A (ja) | 顔料微粒子の表面処理方法 |